Due Diligence for Investors in PharmaCyte Biotech, Inc.
We’ve included below, a company press release that describes a potential roadmap to Diabetes treatment with the PMCB platform. We also listed a PMCB press release that includes a link to a radio interview by Stock Market Media Group with Pharmacyte CEO Kenneth L. Waggoner and COO Dr. Gerald W. Crabtree. The interview is a “must hear” for PMCB investors. We linked a press release from Goldman Small Cap Research that discusses recent industry developments that could benefit PMCB. The article also has a link to a full research report.
Our View: The live-cell encapsulation technology employed by Pharmacyte Biotech encloses living cells in protective “cocoons” about the size of the head of a pin. Each capsule can enclose approximately 10,000 cells and the development of this platform could lead to various disease treatments.
The company’s best potential may be in the treatment of Type I and Type II diabetes. The concept is to create an “artificial” pancreas by encapsulating cells that store and secrete insulin, eliminating the need for insulin shots. The market for diabetes treatment is huge; some research companies have estimated the diabetes treatment market will exceed $80 billion before 2020.
The FDA’s new position of being more accepting of new cancer treatment platforms should bode well for PMCB as well. If the company can show in clinical trials that its technology for treating pancreatic cancer is better than what is available now; that development could open the door for the PMCB Cell-in-a-Box platform to be accepted for trials in other areas such as diabetes.
We believe that the combination of the PMCB platform potential given the size of the diabetes market, combined with the low price around $.10 per share may indicate good investor potential.
PMCB – Press Release – November 3, 2015
Goldman Small Cap Research – Press Release – October 26, 2015
PMCB – Press Release with Radio Interview – October 23, 2015
Our reports/releases are a commercial advertisement and are for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. Broadstreetalerts.com has not been compensated in any form by any entity for information shared on this post.
PLEASE NOTE: Broadstreetalerts.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold Broadstreetalerts.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Broadstreetalerts.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Broadstreetalerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Broadstreetalerts.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Broadstreetalerts.com is compliant with the Can Spam Act of 2003. Broadstreetalerts.com does not offer such advice or analysis, and Broadstreetalerts.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, Broadstreetalerts.com has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Broadstreetalerts.com com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Broadstreetalerts.com is not responsible for any claims made by the companies advertised herein, nor is Broadstreetalerts.com responsible for any other promotional firm, its program or its structure.